Can CMV infection be prevented in Cancer Patients?
Preventing CMV infection in cancer patients involves a combination of strategies. Screening for CMV before starting cancer treatment can help identify patients at risk. Prophylactic antiviral therapy may be considered for high-risk patients, although this approach must be balanced against potential drug toxicity. Adopting stringent infection control practices, including proper hand hygiene and avoiding close contact with individuals who have active CMV infection, can also reduce the risk of transmission.
